Clinico-pathological associations of serum VCAM-1 and ICAM-1 levels in patients with lupus nephritis.
Kelvin Yc YuSusan YungMel Km ChauColin So TangDesmond Yh YapAlexander Hn TangShirley Ky YingCheuk Kwong LeeTak Mao ChanPublished in: Lupus (2021)
Our findings suggest potential utility of serum VCAM-1 and ICAM-1 in clinical management. Monitoring VCAM-1 may facilitate early diagnosis of flare. Combining selected biomarkers may be advantageous in diagnosing active LN. VCAM-1 may have a pathogenic role in renal parenchymal inflammation in active LN.